Alemtuzumab is a RESTRICTED formulary product. Procurement is restricted to a manufacturer controlled distribution program that requires patient specific ordering after patient is approved from Clinigen Direct. Stock may not be used on any patient other than the approved patient it was ordered for without approval from a pharmacy supervisor.
From Lexi:
Campath is no longer commercially available in the United States; a restricted distribution program will allow access for appropriate patients. Information on necessary documentation and requirements is available from Clinigen Direct (1-877-768-4303) or https://www.clinigengroup.com/direct/en-gb/contact-us/#address-13.
Add Formweb to your mobile device
Alemtuzumab is a RESTRICTED formulary product. Procurement is restricted to a manufacturer controlled distribution program that requires patient specific ordering after patient is approved from Clinigen Direct. Stock may not be used on any patient other than the approved patient it was ordered for without approval from a pharmacy supervisor.
From Lexi:
Campath is no longer commercially available in the United States; a restricted distribution program will allow access for appropriate patients. Information on necessary documentation and requirements is available from Clinigen Direct (1-877-768-4303) or https://www.clinigengroup.com/direct/en-gb/contact-us/#address-13.